COMPASS Pathways (CMPS)
(Delayed Data from NSDQ)
$4.34 USD
-0.01 (-0.23%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.38 +0.04 (0.92%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
COMPASS Pathways PLC Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical Services industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CMPS 4.34 -0.01(-0.23%)
Will CMPS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CMPS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CMPS
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know
CMPS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CMPS
Compass Pathways: Overly Confident Management Or Overly Skeptical Market
Compass Pathways (CMPS) Rating Maintained at Buy by Canaccord Genuity | CMPS Stock News
Compass Pathways PLC (CMPS) Q2 2025 Earnings Call Highlights: Clinical Success and Strategic ...
Q2 2025 Compass Pathways PLC Earnings Call Transcript
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks